Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/1995
10/12/1995CA2186962A1 Antibacterial therapy with genotypically modified bacteriophage
10/12/1995CA2186913A1 Compositions and methods for delivery of genetic material
10/12/1995CA2186908A1 .alpha.-1-antichymotrypsin analogues having elastase inhibitory activity
10/12/1995CA2186859A1 Molecular cloning and expression of a .gamma.-interferon inducible activator of the proteasome
10/12/1995CA2186857A1 Monoclonal antibody to oncofetal protein for treating and detecting cancer
10/12/1995CA2186854A1 Human interleukin variants generated by alternative splicing
10/12/1995CA2186737A1 Nematicidal proteins
10/12/1995CA2186636A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects
10/12/1995CA2186635A1 .alpha.-1-antichymotrypsin analogues having chymase inhibiting activity
10/12/1995CA2186516A1 Afamin: a human serum albumin-like protein
10/12/1995CA2186469A1 The isolation and production of catalytic antibodies using phage technology
10/12/1995CA2186107A1 Use of dna oligomers for inhibition of hiv by decreasing ribosomal frameshifting
10/12/1995CA2185211A1 Agonist antibodies against the flk2/flt3 receptor and uses thereof
10/12/1995CA2184261A1 Alphavirus cdna vectors
10/12/1995CA2182966A1 Enzymatic antimicrobial compositions
10/12/1995CA2163662A1 Dna sequencing by stepwise ligation and cleavage
10/11/1995EP0676643A2 System for contamination-free reaction processes
10/11/1995EP0676476A1 Isothermal strand displacement nucleic acid amplification
10/11/1995EP0676474A1 Cloning and expression of a hybrid transforming growth factor-beta-1/transforming growth factor-beta-2
10/11/1995EP0676473A2 Almond n-glycosidase gene
10/11/1995EP0676472A1 Human manganese superoxide dismutase (hMn-SOD)
10/11/1995EP0676471A2 Effector proteins of rapamycin
10/11/1995EP0676470A1 Stem cell factor
10/11/1995EP0676468A2 Human T-cellreceptors, their uses in diagnosis and therapy of diabetes mellitus
10/11/1995EP0676413A2 Interferon-alpha/beta binding protein, its preparation and use
10/11/1995EP0676052A1 Detection of cystic fibrosis or a cftr gene mutation
10/11/1995EP0675969A1 Improved method for amplification of targeted segments of nucleic acid using nested polymerase chain reaction.
10/11/1995EP0675967A1 Functional assay for tumor suppressor genes
10/11/1995EP0675966A1 Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids
10/11/1995EP0675965A1 Polynucleotide immobilized support
10/11/1995EP0675964A1 HUMAN CYCLOOXYGENASE-2cDNA AND ASSAY FOR EVALUATING INHIBITION OF CYCLOOXYGENASE-2.
10/11/1995EP0675963A1 Method and apparatus for enzymatic synthesis of oligonucleotides
10/11/1995EP0675962A1 Synthetic herpes simplex virus promoters
10/11/1995EP0675961A1 Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis)
10/11/1995EP0675960A1 Plants genetically enhanced for disease resistance
10/11/1995EP0675959A1 Dna amplification
10/11/1995EP0675958A1 Nucleotide sequence encoding carbamoyl phosphate synthetase ii
10/11/1995EP0675957A1 Vaccines against varicella-zoster virus (vzv)
10/11/1995EP0675956A1 New protein from urine named component b
10/11/1995EP0675955A1 Molecular flashlight
10/11/1995EP0675954A1 Deblocking the common pathway of aromatic amino acid synthesis
10/11/1995EP0675953A1 Soluble peptides having constrained, secondary conformation in solution and method of making same
10/11/1995EP0675951A1 An enzyme with endoglucanase activity
10/11/1995EP0675950A1 An enzyme with polygalacturonase activity
10/11/1995EP0675949A1 Recombinant lipase and alpha-amylase variants
10/11/1995EP0675904A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus
10/11/1995EP0675903A1 Bone resorption assay
10/11/1995EP0675735A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof
10/11/1995EP0675734A1 ALLERGEN-SPECIFIC IgA MONOCLONAL ANTIBODIES AND RELATED PRODUCTS FOR ALLERGY TREATMENT
10/11/1995EP0629129A4 Method for kidney tubulogenesis.
10/11/1995EP0528906B1 STEROID 5$g(a)-REDUCTASES
10/11/1995EP0460167B1 Humanised antibodies
10/11/1995EP0397700B1 Sf-25 colon adenocarcinoma antigen, and antibodies which recognize this antigen
10/11/1995CN1109908A Productive process and use of human anti-tumour alpha type interferon alpha 1/114 Ala, alpha 1/158 Val and mutant thereof
10/11/1995CN1109907A Constitution of gene synthesized expressive plasmid for human Inter leukin-2 gene and producing process of its products
10/11/1995CN1109784A Hepatitis B surface antigen protein having ammonia end with pre-surface antigen determinant
10/11/1995CN1029989C Method for preparing the xenogeneic albumen from streptomyces
10/11/1995CN1029988C 水蛭素衍生物 Hirudin derivatives
10/11/1995CN1029977C Human insulin analogues
10/10/1995US5457281 Dicot plants containing an antisense polygalacturonase gene segment
10/10/1995US5457195 Sapphyrin derivatives and conjugates
10/10/1995US5457191 3-deazapurines
10/10/1995US5457189 Antisense oligonucleotide inhibition of papillomavirus
10/10/1995US5457182 An isolated, purified homogeneous polypeptide having a specific binding the immunosuppressant, but not cyclosporine
10/10/1995US5457179 Coleopteran-active Bacillus thuringiensis toxin
10/10/1995US5457089 Muteins of human erythropoietin, the preparation thereof and the use thereof
10/10/1995US5457050 Agarose plug mold and processing chamber
10/10/1995US5457049 Tumor suppressor protein pRb2, related gene products, and DNA encoding therefor
10/10/1995US5457048 Eph-related tyrosine kinases, nucleotide sequences and methods of use
10/10/1995US5457047 DNA Sequences coding for PTH variants, PTH variants, expression vector, bacterial host, use and therapeutic composition
10/10/1995US5457046 Polypeptides
10/10/1995US5457042 Sod polypeptide analogs
10/10/1995US5457041 Needle array and method of introducing biological substances into living cells using the needle array
10/10/1995US5457038 Natural killer stimulatory factor
10/10/1995US5457037 From Pseudomonas
10/10/1995US5457035 Cytokine which is a ligand for OX40
10/10/1995US5457034 Vectors for expression of NGF in eukaryotic cells
10/10/1995US5457033 Producing polypeptide with methionine residue at amino end and glycine residue at carboxyl end by recombinant DNA methods, enzymatically cleaving to polypeptide carboxamide
10/10/1995US5457032 Mutated β-lactam acylase genes
10/10/1995US5457029 Nuclear antigen La
10/10/1995US5457025 Solid phase hybrid analysis
10/10/1995US5456909 Used in therapy and diagnosis of inflammatory and immune disorders
10/10/1995US5456360 Holder assembly for reaction tubes
10/10/1995CA1337283C Method for the selective cleavage of fusion proteins
10/10/1995CA1337281C Cloning of cdnas for interferon-induced genes and their use for monitoring the response to interferon
10/10/1995CA1337280C Production of proteins in plants
10/10/1995CA1337269C Vaccine against brucella abortus
10/05/1995WO1995026412A1 Ligands added to adenovirus fiber
10/05/1995WO1995026411A2 Composition and methods for creating syngeneic recombinant virus-producing cells
10/05/1995WO1995026410A2 Biological insect control agent
10/05/1995WO1995026409A1 RECOMBINANT ADENOVIRUSES CODING FOR BASIC FIBROBLAST GROWTH FACTORS (bFGF)
10/05/1995WO1995026408A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf)
10/05/1995WO1995026407A1 Method for producing altered starch from potato plants
10/05/1995WO1995026406A2 Riboflavin synthesis in fungi
10/05/1995WO1995026405A1 T-lymphotropic primate virus l (ptlv-l) and its applications
10/05/1995WO1995026404A1 Cell-surface polypeptide gene
10/05/1995WO1995026402A1 Vaccines against helminthic parasites
10/05/1995WO1995026401A1 Method for the permanent expression of glutamate receptors
10/05/1995WO1995026400A1 Reverse two-hybrid method
10/05/1995WO1995026397A1 Alkaline bacillus amylase